Amedisys, Inc. (“Company”), one of America's leading home health nursing companies, today announced that it will host a conference call with the investment community on Tuesday, October 28, 2008 at 10:00 a.m. ET to discuss its financial and business performance. The Company intends to release its financial results for the quarter and nine months ended September 30, 2008 pre-market on Tuesday, October 28, 2008.
To participate in the conference call, please dial 888-686-9695 (Domestic) or 913-312-1433 (International) a few minutes before 10:00 a.m. ET on Tuesday, October 28, 2008. A replay of the conference call will be available from 1:00 p.m. ET on October 28, 2008 through November 4, 2008. The replay dial in number is 888-203-1112 (Domestic) or 719-457-0820 (International). The replay pin number is 2408709.
The call will also be available on the Internet live and in our archived section thereafter on our Investor Relations page at the following web address:
http://www.amedisys.com/investors
Amedisys, Inc. (the “Company”) is headquartered in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq Global Select Market under the symbol “AMED.”
Contact:
Amedisys, Inc.
Kevin LeBlanc, 225-292-2031
Director of Investor Relations
kleblanc@amedisys.com
Source: Amedisys, Inc.
To participate in the conference call, please dial 888-686-9695 (Domestic) or 913-312-1433 (International) a few minutes before 10:00 a.m. ET on Tuesday, October 28, 2008. A replay of the conference call will be available from 1:00 p.m. ET on October 28, 2008 through November 4, 2008. The replay dial in number is 888-203-1112 (Domestic) or 719-457-0820 (International). The replay pin number is 2408709.
The call will also be available on the Internet live and in our archived section thereafter on our Investor Relations page at the following web address:
http://www.amedisys.com/investors
Amedisys, Inc. (the “Company”) is headquartered in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq Global Select Market under the symbol “AMED.”
Contact:
Amedisys, Inc.
Kevin LeBlanc, 225-292-2031
Director of Investor Relations
kleblanc@amedisys.com
Source: Amedisys, Inc.
0 comments:
Post a Comment